全文获取类型
收费全文 | 5198篇 |
免费 | 326篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 133篇 |
妇产科学 | 126篇 |
基础医学 | 912篇 |
口腔科学 | 210篇 |
临床医学 | 641篇 |
内科学 | 903篇 |
皮肤病学 | 151篇 |
神经病学 | 599篇 |
特种医学 | 164篇 |
外科学 | 558篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 357篇 |
眼科学 | 74篇 |
药学 | 296篇 |
中国医学 | 8篇 |
肿瘤学 | 328篇 |
出版年
2024年 | 4篇 |
2023年 | 45篇 |
2022年 | 64篇 |
2021年 | 118篇 |
2020年 | 93篇 |
2019年 | 105篇 |
2018年 | 117篇 |
2017年 | 104篇 |
2016年 | 147篇 |
2015年 | 150篇 |
2014年 | 196篇 |
2013年 | 261篇 |
2012年 | 407篇 |
2011年 | 427篇 |
2010年 | 258篇 |
2009年 | 247篇 |
2008年 | 344篇 |
2007年 | 364篇 |
2006年 | 309篇 |
2005年 | 339篇 |
2004年 | 323篇 |
2003年 | 286篇 |
2002年 | 284篇 |
2001年 | 44篇 |
2000年 | 30篇 |
1999年 | 42篇 |
1998年 | 70篇 |
1997年 | 45篇 |
1996年 | 28篇 |
1995年 | 38篇 |
1994年 | 28篇 |
1993年 | 25篇 |
1992年 | 22篇 |
1991年 | 12篇 |
1990年 | 16篇 |
1989年 | 10篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 9篇 |
1984年 | 12篇 |
1983年 | 6篇 |
1982年 | 17篇 |
1981年 | 13篇 |
1980年 | 4篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1975年 | 5篇 |
1974年 | 5篇 |
排序方式: 共有5542条查询结果,搜索用时 15 毫秒
51.
Hagen Sjard Bachmann Werner Meier Andreas du Bois Rainer Kimmig Jan Dominik Kuhlmann Winfried Siffert Jalid Sehouli Kerstin Wollschlaeger Jens Huober Peter Hillemanns Alexander Burges Barbara Schmalfeldt Behnaz Aminossadati Pauline Wimberger 《British journal of clinical pharmacology》2015,80(5):1139-1148
Aim
Despite promising preclinical findings regarding clinical utility of farnesyltransferase inhibitors (FTI), such as lonafarnib, success of clinical trials is limited. A multicentre AGO-OVAR-15 phase II trial reported an unfavourable effect of lonafarnib on the outcome of patients with advanced ovarian cancer. This study was performed as a genetic subgroup analysis of the AGO-OVAR-15 trial, and investigated the utility of the promoter polymorphism rs11623866 of the farnesyltransferase ß-subunit gene (FNTB) in predicting the clinical effectiveness of lonafarnib.Methods
The influence of rs11623866 (c.-609G > C) on FNTB promoter activity was investigated by electrophoretic-mobility-shift assay, luciferase-reporter assay and RT-qPCR. A total of 57 out of 105 patients from the AGO-OVAR-15 trial, treated with carboplatin and paclitaxel ± lonafarnib, was genotyped for rs11623866 by restriction fragment length polymorphism analysis. Genotype-dependent survival analysis was performed by Kaplan–Meier analysis.Results
The presence of the G allele was associated with increased FNTB promoter activity compared with the C allele. An unfavourable effect of lonafarnib was limited to patients carrying a GG genotype (HRPFS 6.2, 95%CI = 2.01, 19.41, P = 0.002; HROS 9.6, 95%CI = 1.89, 48.54, P = 0.006). Median progression free survival (PFS) for patients with the GG genotype in the lonafarnib treated arm was 10 months, whereas median PFS without FTI-treatment was 40 months. Median overall survival (OS) in the lonafarnib-treated group was 19 months, whereas median OS was not reached in the untreated group.Conclusions
Discrepancies between preclinical success and clinical failure may be due to the patients'' genetic variability of FNTB. Therefore, our results may encourage retrospective evaluation of FNTB polymorphisms in previous FTI studies, especially those reporting positive FTI response. 相似文献52.
53.
The induction of 2F5- and 4E10-like antibodies broadly neutralising HIV-1 and targeting the membrane external proximal region (MPER) of the transmembrane envelope protein gp41 would be a major advancement for the development of a preventive HIV-1 vaccine, but successful attempts remain rare. Recent studies demonstrated that broadly reactive antibodies develop relatively late during infection and after intensive affinity maturation. Therefore, a prolonged antigen delivery might be beneficial to induce them. Replicating foamy viruses which are characterised by apathogenic but persistent infection could represent suitable carrier viruses for this purpose. In order to develop such a system, we modified the accessory foamy virus Bet protein to contain the MPER of gp41, or the MPER linked to the stabilising fusion peptide proximal region of gp41 and analysed here the antigenic and immunogenic properties of such hybrid proteins. The antigens, expressed and purified to homogeneity, were recognised by the monoclonal antibodies 2F5 and 4E10 with nanomolar affinities and induced high levels of antibodies specific to gp41 after immunisation of rats. The antisera also bound to virus particles attached to infected cells, and peptide-based epitope mapping showed that they recognised the 2F5 epitope. Although no HIV-1 neutralising activity was observed, the presented data demonstrate that using the foamy virus Bet for HIV-1 epitope delivery is successfully applicable. Together with the attractive potential for sustained antigen expression after transfer to replicating virus, these results should therefore provide a first basis for the development of chimeric foamy viruses as novel HIV-1 vaccine vectors. 相似文献
54.
Christina Janko Christine Schorn Daniela Weidner Kerstin Sarter Ricardo Chaurio Ahmed Sheriff 《Autoimmunity》2013,46(4):286-288
CRP is an important inflammatory marker, however, CRP levels are relatively low in patients with SLE. In addition patients with SLE often display low activities and serum levels for DNase I and complement, respectively. Here we show that DNase I treatment of nec PBMC increased their binding of CRP. Consequently, reduced DNase I activity in patients with SLE may contribute to the impaired opsonisation by CRP of dead cells, exacerbating the clearance defect in SLE of apo and nec cells. 相似文献
55.
Changes in the activity and number of natural killer (NK) cells in peripheral blood in patients with autoimmune thyroid disease were examined. NK activity was measured in a 4-hr 51Cr-release assay and the number of NK cells was analyzed with FITC-conjugated monoclonal antibodies by use of an automated flow cytometer. NK activity in patients with untreated Graves' disease (n=25, 39.7+13.5%, P<0.05) and Hashimoto's thyroiditis (n=18, 41.0±14.2%, P<0.05) was high compared to the activity in non-pregnant controls (n=61, 32.6±15.0%). NK activity in patients with postpartum Graves' thyrotoxicosis (n=11, 48.6±18.9%) was markedly increased compared to the activity in non-pregnant controls (P<0.01) and in postpartum controls (n=29, 33.8±15.2%, P<0.05), although the mean ages of each group did not differ significantly. Moreover, NK activities in the thyrotoxic state were significantly higher than those in the euthyroid state in the same patients with postpartum Graves' thyrotoxicosis or with postpartum destructive thyrotoxicosis. The number of CD16 positive cells increased in patients with postpartum Graves' thyrotoxicosis. However the number of CD 16 and CD57 positive cells were normal in all other groups of patients. These results indicate that an increase of NK activity is associated with exacerbation of autoimmune thyroid disease both in Hashimoto's thyroiditis and in Graves' disease and suggest that NK cells might have an important role for the control of disease activity in autoimmune thyroid disease. 相似文献
56.
57.
58.
59.
Sebastian Reuther Silke Szymczak Annette Raabe Kerstin Borgmann Andreas Ziegler Cordula Petersen Ekkehard Dikomey Ulrike Hoeller 《Strahlentherapie und Onkologie》2015,191(1):59-66
Background and purpose
The aim of this study was to determine the impact of functional single nucleotide polymorphism (SNP) pathways involved in the ROS pathway, DNA repair, or TGFB1 signaling on acute or late normal toxicity as well as individual radiosensitivity.Materials and methods
Patients receiving breast-conserving surgery and radiotherapy were examined either for erythema (n?=?83), fibrosis (n?=?123), or individual radiosensitivity (n?=?123). The 17 SNPs analyzed are involved in the ROS pathway (GSTP1, SOD2, NQO1, NOS3, XDH), DNA repair (XRCC1, XRCC3, XRCC6, ERCC2, LIG4, ATM) or TGFB signaling (SKIL, EP300, APC, AXIN1, TGFB1). Associations with biological and clinical endpoints were studied for single SNPs but especially for combinations of SNPs assuming that a SNP is either beneficial or deleterious and needs to be weighted.Results
With one exception, no significant association was seen between a single SNP and the three endpoints studied. No significant associations were also observed when applying a multi-SNP model assuming that each SNP was deleterious. In contrast, significant associations were obtained when SNPs were suggested to be either beneficial or deleterious. These associations increased, when each SNP was weighted individually. Detailed analysis revealed that both erythema and individual radiosensitivity especially depend on SNPs affecting DNA repair and TGFB1 signaling, while SNPs in ROS pathway were of minor importance.Conclusion
Functional pathways of SNPs may be used to form a risk score allowing to predict acute and late radiation-induced toxicity but also to unravel the underlying biological mechanisms.60.